METIS PHARMACEUTICALS
METiS Pharmaceuticals is the world's first AI-driven drug formulation company.
METIS PHARMACEUTICALS
Industry:
Artificial Intelligence Biopharma Medical Device Pharmaceutical
Founded:
2020-01-01
Address:
Hangzhou, Zhejiang, China
Country:
China
Website Url:
http://www.metispharmaceuticals.cn
Total Employee:
51+
Status:
Active
Contact:
+86 0571-86015326
Email Addresses:
[email protected]
Total Funding:
236 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Mobile Non Scaleable Content CNZZ Baidu Maps
Similar Organizations
AccutarBio
AccutarBio employs artificial intelligence to revolutionize drug discovery.
Blade Therapeutics
Blade Therapeutics is a discovery stage drug development company.
Corvus Pharmaceuticals
Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company.
Curon Biopharma
Curon Biopharma is a Healthcare company.
Hangzhou Just Biotherapeutics (Just China)
Hangzhou Just Biotherapeutics is a comprehensive high-tech design company.
KSQ Therapeutics
KSQ Therapeutics is using CRISPR technology within a powerful drug discovery engine to enable high-confidence drug development.
METiS Therapeutics
METiS Therapeutics uses integrated drug discovery to develop medicines in a variety of illness areas.
Sirnaomics
Sirnaomics is a biopharmaceutical company developing therapeutics for critical human diseases by using RNA interference technology.
StoneWise
StoneWise is committed to establishing the world's leading intelligent drug discovery platform.
Aria Pharmaceuticals
Aria Pharmaceuticals is a artificial intelligence-driven biopharmaceutical company.
Current Employees Featured
Founder
Investors List
PICC Capital Investment Management
PICC Capital Investment Management investment in Series B - METiS Pharmaceuticals
5Y Capital
5Y Capital investment in Series B - METiS Pharmaceuticals
China Life Investment Holding
China Life Investment Holding investment in Series B - METiS Pharmaceuticals
Lightspeed China Partners
Lightspeed China Partners investment in Series B - METiS Pharmaceuticals
CMB International Capital Corporation
CMB International Capital Corporation investment in Series B - METiS Pharmaceuticals
Sequoia Capital China
Sequoia Capital China investment in Series B - METiS Pharmaceuticals
FREES FUND
FREES FUND investment in Series B - METiS Pharmaceuticals
Monolith Management
Monolith Management investment in Series B - METiS Pharmaceuticals
Sequoia Capital China
Sequoia Capital China investment in Series A - METiS Pharmaceuticals
CMBI Zhaoxin Wuji Fund
CMBI Zhaoxin Wuji Fund investment in Series A - METiS Pharmaceuticals
Official Site Inspections
http://www.metispharmaceuticals.cn
- Host name: 47.96.124.162
- IP address: 47.96.124.162
- Location: Hangzhou China
- Latitude: 30.294
- Longitude: 120.1619
- Timezone: Asia/Shanghai
More informations about "METiS Pharmaceuticals"
剂泰医药 METiS - AI驱动药物递送和药物发现
METiS is a biotechnology company that aims to address unmet medical needs by applying AI, machine learning and quantum simulation to drug delivery and drug discovery, and achieve …See details»
剂泰医药 METiS - AI驱动药物递送和药物发现 - Metis …
METiS is a biotechnology company that aims to address unmet medical needs by applying AI, machine learning and quantum simulation to drug delivery and drug discovery, and achieve optimal therapies across a broad spectrum of diseases.See details»
METiS Pharmaceuticals - LinkedIn
METiS is an innovative biotechnology company driven by artificial intelligence (AI) that harnesses targeted drug delivery technology to develop more effective drugs for patients.See details»
剂泰医药 METiS - AI驱动药物递送和药物发现 - Metis Pharma
METiS is an innovative biotechnology company driven by artificial intelligence (AI) that harnesses targeted drug delivery and discovery technology to develop more effective drugs for patients.See details»
METiS Pharmaceuticals - Crunchbase Company Profile & Funding
METiS Pharmaceuticals is the world's first AI-driven drug formulation company. Jitai Medicine (METiS) is a biotechnology company that uses artificial intelligence to drive drug delivery and …See details»
METiS Therapeutics | AI drug discovery
METiS focuses on leveraging Artificial Intelligence (AI), Machine Learning (ML), and Molecular Dynamics (MD) to develop novel therapeutics in the small molecule, biologics, and advanced …See details»
Metis Pharmaceuticals - Craft
Metis Pharmaceuticals (also known as Hangzhou Jiantai Pharmaceutical Technology, 杭州剂泰医药科技有限责任公司) is a company that specializes in artificial intelligence solutions for drug …See details»
Metis Therapeutics - MassBio
METis Pharmaceuticals Inc is a biotechnology company with a unique technology platform that has the potential to drive best-in class drug assets in a wide range of therapeutic areas.See details»
Metis Pharmaceuticals (杭州剂泰医药科技有限责任公司): 药物管 …
了解Metis Pharmaceuticals (杭州剂泰医药科技有限责任公司)公司的药物管线，治疗领域，技术平台，以及它的30篇新闻。See details»
Metis Pharmaceuticals - PitchBook
Developer of an artificial intelligence platform designed to optimize pharmaceutical formulation processes. The company's software helps pharmaceutical companies accelerate the …See details»
Metis Pharmaceuticals
评价试验药物MTS004在继发于包括肌萎缩侧索硬化症（ALS）、多发性硬化症（MS）、脑卒中、创伤性脑损伤（TBI）或帕金森病（PD）在内的神经系统疾病的假性延髓情绪（PBA）患者中 …See details»
METiS Pharmaceuticals - VentureRadar
Website: http://metispharmaceuticals.cn/ Develops AI-driven drug discovery and delivery platform, with over 10 pipelines including small molecule and mRNA-based nucleic acid drugs, backed …See details»
剂泰医药 METiS - AI驱动药物递送和药物发现 - Metis Pharma
With our industry-leading platform of “AI+ drug delivery and drug discovery”, METiS has forged partnerships with many domestic and international pharmaceutical companies for collaborative …See details»
METiS Pharmaceuticals CEO, Founder, Key Executive Team, Board …
Explore {METiS Pharmaceuticals's key management people. Discover current leadership team members including founders, CEO, other executives and board directors.See details»
Metis Pharmaceuticals - Company info. interviews, news
METiS Pharmaceuticals Inc is the world’s first AI-driven drug formulation company. Through the integration of machine learning, quantum simulation, and high-throughput experimentation, we …See details»
剂泰医药 | 项目信息-36氪
剂泰医药（METiS Pharmaceuticals）是全球首家以人工智能驱动药物制剂开发的初创公司，团队结合了突破性的高通量制剂实验平台及前沿计算物理、人工智能与云计算等技术，致力于快速 …See details»
36氪独家 | 用AI瞄准千亿级制剂改良市场，「METiS」连续完成红 …
在AI制药赛道上，METiS是一家独特的企业，是全球首家以人工智能驱动“制剂优化”，通过制剂改进原药性质，从而提升新药开发效率的公司。 AI制药是通过人工智能算法提升新药开发效率 …See details»
剂泰医药完成1亿美元C轮融资医药新闻-ByDrug-一站式医药资源共 …
Jun 23, 2024 · 剂泰医药（METiS Pharmaceuticals）成立于2020年，是一家以AI驱动药物递送和药物发现的创新型生物技术公司。 剂泰医药旨在通过将全新的AI、机器学习和量化模拟等先 …See details»
人工智能驱动药物制剂开发公司「METiS」宣布完成数百万美元天 …
Mar 24, 2020 · METiS 是全球首家以人工智能驱动药物制剂开发的新创公司。 致力以高通量制剂平台及人工智能计算等技术，为药企提供快速、精确的智能化制剂研发，并在癌症、传染性疾病 …See details»
剂泰医药完成1亿美元C轮融资，领跑"AI+药物递送"赛道
北京2024年6月24日 /美通社/ -- 2024年6月21日，专注"AI+药物递送"的创新型生物技术公司 剂泰医药（METiS Pharmaceuticals）宣布完成1亿美元的C轮融资， 本轮融资由 中金 资本旗下基金 …See details»